25 Susceptibility to AKI varies across individuals depending on non-modifiable factors (eg, comorbidities), modifiable factors (eg, sepsis, nephrotoxic drugs), and factors related to liver disease (eg ...

Mallinckrodt has finally claimed FDA approval for terlipressin as a treatment for hepatorenal syndrome (HRS), after ... defined as renal function improvement, avoidance of dialysis, and short ...

Renal injury in patients with cardiac dysfunction is difficult to diagnose and treat in a timely manner. Increased understanding of the cardiorenal syndrome is making the complex interactions ...

Acute kidney injury (AKI) is a common, heterogeneous, multifactorial condition, which is part of the overarching syndrome of acute kidney diseases and disorders. This condition’s incidence highest in ...

Aki India Ltd., incorporated in the year 1994, is a Mid Cap company (having a market cap of Rs 100.66 Crore) operating in Miscellaneous sector. Aki India Ltd. key Products/Revenue Segments include ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

Objectives This study aimed to assess whether the combined use of proton pump inhibitors (PPIs) with non-steroidal anti-inflammatory drugs (NSAIDs) or antibiotics (penicillins, macrolides, ...

Reviewing literature of rifampin-induced AKI, [4,11–13] the mean age of reported cases is around 40–45 years and the recovery rate ranges from 83% to 96%. However, the incidence to rifampin ...